Takeda Pharmaceutical Company
Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries.
Current Price
$16.68
+0.60%GoodMoat Value
$44.87
169.0% undervaluedTakeda Pharmaceutical Company (TAK) Stock News
TAK Stock News & Headlines
Latest stock news and headlines for Takeda Pharmaceutical Company (TAK). Stay informed on earnings reports, analyst upgrades and downgrades, market-moving events, and company announcements.
Current stock price: $16.68. Market cap: $52.11B. Sector: Healthcare. Industry: Drug Manufacturers - Specialty & Generic. This page aggregates the latest news articles relevant to TAK from financial news sources, helping investors stay current on events that may impact Takeda Pharmaceutical Company's stock price.
News catalysts can drive significant short-term price movement. Earnings surprises, management changes, product launches, regulatory decisions, and analyst coverage changes all create opportunities and risks. Combine news monitoring with GoodMoat's fundamental analysis, quality scores, and valuation tools for a complete research workflow on Takeda Pharmaceutical Company (TAK).